ADC Therapeutics SA (ADCT) Misses Q1 EPS by 57c

ADC Therapeutics SA (NYSE: ADCT) reported Q1 EPS of ($0.53), $0.57 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $18.99 million versus the consensus estimate of $20.29 million.

For earnings history and earnings-related data on ADC Therapeutics SA (ADCT) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
• Baozun Inc. (BZUN) Reports Q2 EPS of RMB0.42